LatentSpace Therapeutics is revolutionizing drug discovery by intentionally designing best-in-class medicines from inception. Our advanced AI-driven platform, ✦PULSAR✦, analyzes extensive pharmacological data to identify patterns in drug efficacy and safety, enabling the rapid generation of novel chemical entities with superior therapeutic windows. By integrating comprehensive in-silico testing--including retrosynthesis, toxicity, and efficacy assessments--we accelerate the selection of development candidates, significantly reducing both time and cost in bringing effective treatments to patients.
We are building an advanced ML/AI platform that leverages real-world evidence to pioneer the development of novel medicines for complex diseases. At the core of our technology is ✦PULSAR✦, our drug design platform trained on thousands of compounds and sequencing datasets from pharmacology experiments to create cellular potency prediction models. ✦PULSAR✦ is designed to find and generate best in class new chemical entities with large therapeutic windows while also considering novel intellectual property.
LatentSpace Therapeutics, LLC. © Copyright 2024-2025. All Rights Reserved.